Literature DB >> 18826366

Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.

Daniel M Prevedello1, Nader Pouratian, Jonathan Sherman, John A Jane, Mary Lee Vance, M Beatriz Lopes, Edward R Laws.   

Abstract

OBJECT: Outcomes of therapy for Cushing's disease (CD) vary depending on different aspects of presentation and diagnostic studies. The authors designed this study to verify the remission rate and outcomes after transsphenoidal surgery (TSS) for patients with CD who had positive findings on MR imaging.
METHODS: Patients who had presented with CD at the University of Virginia for initial treatment between July 1992 and December 2005 were retrospectively reviewed. The patients included in the study were considered to be optimal surgical candidates, defined as an adult (>18 years of age) with classic clinical features of CD, laboratory studies confirming a central (pituitary/hypothalamic) adrenocorticotropic hormone-dependent source of disease, and an MR imaging study revealing a microadenoma in the sella turcica.
RESULTS: A total of 167 patients fulfilled the criteria. Thirty were men (18%) and 137 were women (82%). The mean age was 42.3 years (range 18.2-77 years). All patients underwent TSS. Surgical remission was achieved in 148 patients (88.6%), which was correlated with the surgeon's intraoperative identification of an adenoma (p=0.03). Histopathological confirmation of an adrenocorticotropic hormone-secreting adenoma strongly correlated with remission (p=0.0001). Three patients (1.8%) had postoperative cerebrospinal fluid leaks, and 1 patient had meningitis. Transient diabetes insipidus was diagnosed and treated in 10 patients (6%), whereas permanent diabetes insipidus occurred in 8 patients (4.8%). Panhypopituitarism followed the surgery in 14 patients (8.3%), 13 of whom underwent total hypophysectomy (9 initially and 4 with early reoperations), and in 1 of 10 patients who underwent subtotal hypophysectomy. Nineteen patients (12.8%) who were initially in remission developed recurrent CD after an average of 50 months. The mean follow-up for the 167 patients was 39 months (range 6-157 months). Gamma Knife surgery was the most common modality of radiotherapy used to treat 31 patients (18.5%) who did not achieve remission or later presented with recurrent disease. Bilateral adrenalectomies were performed in 10 patients in the series (6%), 2 of whom developed Nelson's syndrome. The overall posttreatment remission rate was 95.8%.
CONCLUSIONS: Even in patients with ideal diagnostic criteria of CD, there remain a significant number of cases in which TSS alone is not adequate to assure long-lasting remission. A multidisciplinary approach is essential to the achievement of satisfactory overall remission rates.

Entities:  

Mesh:

Year:  2008        PMID: 18826366     DOI: 10.3171/JNS/2008/109/10/0751

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  28 in total

Review 1.  Surgical management of Cushing's disease.

Authors:  Robert F Dallapiazza; Edward H Oldfield; John A Jane
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

2.  Intraoperative multiple-staged resection and tumor tissue identification using frozen sections provide the best result for the accurate localization and complete resection of tumors in Cushing's disease.

Authors:  Jung Soo Lim; Seung Ku Lee; Se Hoon Kim; Eun Jig Lee; Sun Ho Kim
Journal:  Endocrine       Date:  2011-06-19       Impact factor: 3.633

3.  Selective inferior petrosal sinus sampling without venous outflow diversion in the detection of a pituitary adenoma in Cushing's syndrome.

Authors:  Lukas Andereggen; Gerhard Schroth; Jan Gralla; Rolf Seiler; Luigi Mariani; Jürgen Beck; Hans-Rudolf Widmer; Robert H Andres; Emanuel Christ; Christoph Ozdoba
Journal:  Neuroradiology       Date:  2011-08-02       Impact factor: 2.804

Review 4.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

5.  Determinants of outcome of transsphenoidal surgery for Cushing disease in a single-centre series.

Authors:  A L Serban; G Del Sindaco; E Sala; G Carosi; R Indirli; G Rodari; C Giavoli; M Locatelli; G Carrabba; G Bertani; G Marfia; G Mantovani; M Arosio; E Ferrante
Journal:  J Endocrinol Invest       Date:  2019-11-26       Impact factor: 4.256

6.  The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite.

Authors:  Hasan A Zaidi; Kenneth De Los Reyes; Garni Barkhoudarian; Zachary N Litvack; Wenya Linda Bi; Jordina Rincon-Torroella; Srinivasan Mukundan; Ian F Dunn; Edward R Laws
Journal:  Neurosurg Focus       Date:  2016-03       Impact factor: 4.047

Review 7.  Managing Cushing's disease: the state of the art.

Authors:  Annamaria Colao; Marco Boscaro; Diego Ferone; Felipe F Casanueva
Journal:  Endocrine       Date:  2014-01-11       Impact factor: 3.633

8.  Medical treatment of Cushing's disease: Overview and recent findings.

Authors:  Stephanie Smooke Praw; Anthony P Heaney
Journal:  Int J Gen Med       Date:  2009-12-29

9.  Early promising results for the endoscopic surgical treatment of Cushing's disease.

Authors:  Mustafa Berker; Ilkay Işikay; Dilek Berker; Miyase Bayraktar; Alper Gürlek
Journal:  Neurosurg Rev       Date:  2013-11-15       Impact factor: 3.042

10.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; M Hassan Murad; John Newell-Price; Martin O Savage; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2015-07-29       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.